Serina Therapeutics (SER) Intangibles (2017 - 2024)
Serina Therapeutics (SER) posted Intangibles of $509000.0 for Q3 2024, down 5.91% sequentially from $541000.0 in Q2 2024, and down 20.47% YoY from $640000.0 in Q4 2023.
Serina Therapeutics (SER) Intangibles (2017 - 2024) Analysis & Trends
Serina Therapeutics has reported Intangibles for 8 years, with the latest figure at $509000.0 in Q3 2024.
- Quarterly Intangibles fell 20.47% year-over-year to $509000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $509000.0 (down 20.47% YoY) and the FY2022 annual result came in at $738000.0, down 43.75% from the prior year.
- Intangibles declined to $509000.0 in Q3 2024 per SER's latest filing, from $541000.0 in the prior quarter.
- Over five years, Intangibles peaked at $2.0 million in Q1 2020 and troughed at $509000.0 in Q3 2024.
- A 5-year average of $1.0 million and a median of $869500.0 in 2021 frame the typical range for Intangibles.
- The sharpest annual moves came in 2023 and 2024: Intangibles jumped 63.18% in 2023, then tumbled 58.77% in 2024.
- Over 5 years, Intangibles stood at $1.6 million in 2020, then retreated by 17.59% to $1.3 million in 2021, then sank by 43.75% to $738000.0 in 2022, then declined by 13.28% to $640000.0 in 2023, then declined by 20.47% to $509000.0 in 2024.
- According to Business Quant data, Intangibles over the past three periods registered $509000.0, $541000.0, and $576000.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Serina Therapeutics | 46.70 Mn | 23.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 509,000.00 |
| Jun 30, 2024 | 541,000.00 |
| Mar 31, 2024 | 576,000.00 |
| Sep 30, 2023 | 640,000.00 |
| Jun 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | 705,000.00 |
| Dec 31, 2022 | 738,000.00 |
| Sep 30, 2022 | 771,000.00 |
| Jun 30, 2022 | 804,000.00 |
| Mar 31, 2022 | 837,000.00 |
| Dec 31, 2021 | 1.31 Mn |
| Sep 30, 2021 | 902,000.00 |
| Jun 30, 2021 | 935,000.00 |
| Mar 31, 2021 | 968,000.00 |
| Dec 31, 2020 | 1.59 Mn |
| Sep 30, 2020 | 1.73 Mn |
| Jun 30, 2020 | 1.87 Mn |
| Mar 31, 2020 | 2.01 Mn |
| Dec 31, 2019 | 2.15 Mn |
| Sep 30, 2019 | 2.29 Mn |